BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fujio A, Kawagishi N, Echizenya T, Tokodai K, Nakanishi C, Miyagi S, Sato K, Fujimori K, Ohuchi N. Long-term survival with growth hormone replacement after liver transplantation of pediatric nonalcoholic steatohepatitis complicating acquired hypopituitarism. Tohoku J Exp Med. 2015;235:61-67. [PMID: 25744617 DOI: 10.1620/tjem.235.61] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Jung D, Seo GH, Kim YM, Choi JH, Yoo HW. Hepatopulmonary syndrome caused by hypothalamic obesity and nonalcoholic fatty liver disease after surgery for craniopharyngioma: a case report. Ann Pediatr Endocrinol Metab 2018;23:51-5. [PMID: 29609450 DOI: 10.6065/apem.2018.23.1.51] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Von-hafe M, Borges-canha M, Vale C, Leite AR, Sérgio Neves J, Carvalho D, Leite-moreira A. Nonalcoholic Fatty Liver Disease and Endocrine Axes—A Scoping Review. Metabolites 2022;12:298. [DOI: 10.3390/metabo12040298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zhang XY, Yuan K, Fang YL, Wang CL. Growth hormone ameliorates hepatopulmonary syndrome and nonalcoholic steatohepatitis secondary to hypopituitarism in a child: A case report. World J Clin Cases 2022; 10(18): 6211-6217 [DOI: 10.12998/wjcc.v10.i18.6211] [Reference Citation Analysis]
4 Clemente MG, Mandato C, Poeta M, Vajro P. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions. World J Gastroenterol 2016; 22(36): 8078-8093 [PMID: 27688650 DOI: 10.3748/wjg.v22.i36.8078] [Cited by in CrossRef: 104] [Cited by in F6Publishing: 89] [Article Influence: 17.3] [Reference Citation Analysis]
5 Rai V, Dietz NE, Agrawal DK. Immunological basis for treatment of graft versus host disease after liver transplant. Expert Rev Clin Immunol 2016;12:583-93. [PMID: 26795873 DOI: 10.1586/1744666X.2016.1145056] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
6 Ji B, Zhang M, Zhao Q, Chu Y, Li Y, Pan H, Ban B. Association between Alanine Aminotransferase and Growth Hormone: A Retrospective Cohort Study of Short Children and Adolescents. Biomed Res Int 2019;2019:5939372. [PMID: 31073528 DOI: 10.1155/2019/5939372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Ji W, Nie M, Mao JF, Zhang HB, Wang X, Wu XY. Growth hormone cocktail improves hepatopulmonary syndrome secondary to hypopituitarism: A case report. World J Clin Cases 2021; 9(18): 4852-4858 [PMID: 34222458 DOI: 10.12998/wjcc.v9.i18.4852] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Mazerkina NA, Savateev AN, Gorelyshev SK, Mariashev SA, Beregovskaya SA, Konovalov AN. [Hepatopulmonary syndrome: a rare manifestation of cirrhosis in patient with diencephalic obesity and nonalcoholic fatty liver disease after surgery for craniopharyngioma]. Probl Endokrinol (Mosk) 2021;67:58-66. [PMID: 34766492 DOI: 10.14341/probl12723] [Reference Citation Analysis]
9 Kang SJ, Kwon A, Jung MK, Chae HW, Kim S, Koh H, Shin HJ, Kim HS. High Prevalence of Nonalcoholic Fatty Liver Disease Among Adolescents and Young Adults With Hypopituitarism due to Growth Hormone Deficiency. Endocr Pract 2021:S1530-891X(21)01081-8. [PMID: 34126247 DOI: 10.1016/j.eprac.2021.06.003] [Reference Citation Analysis]